Issue Brief
Consumer Survey - Disclosure of Industry Payments to Physicians
Jun 16, 2008
Americans want to know about physician ties to pharmaceutical companies. More info
Issue Brief
Jun 16, 2008
Americans want to know about physician ties to pharmaceutical companies. More info| Summary | Type |
|---|---|
AAMC: The Scientific Basis of Influence and BiasThe Association of American Medical Colleges recently published "The Scientific Basis of Influence and Bias" based on a symposium held in June 2007 in Washington D.C. More info |
Issue Brief |
Advancing Integrity in Medical EducationThe Pew Charitable Trusts is working to decrease the influence of pharmaceutical marketing on doctors’ practices. With a three-year grant from the Attorney General Consumer and Prescriber Education Grant Program, Pew is collaborating several partners to improve conflict-of-interest policies within the 158 medical schools and 400 major teaching hospitals in the United States. More info |
Other Resource |
Comments to CMS on Sunshine ImplementationPew’s main goals in commenting on the proposed rule are to ensure timely implementation and to promote the interest of full transparency by ensuring that data is collected, reported, and published in the most complete, consistent and accurate manner possible. More info |
Issue Brief |
Consumer Survey - Disclosure of Industry Payments to PhysiciansA majority of Americans say that it is important to know their physician’s financial ties to pharmaceutical companies and support legislation requiring pharmaceutical companies to disclose gifts to doctors. More info |
Issue Brief |
Disclosure of Industry Payments to PhysiciansThis Prescription Project survey shows Americans are eager to understand financial ties between physicians and pharmaceutical industry. More info |
Report |
| Video | |
Federal Reporting Requirements on Payments to Physicians: Impact on State LawsWith the enactment of the Patient Protection and Affordable Care Act in March 2010, all U.S. manufacturers of drugs, devices, biologics or medical supplies covered under government-funded insurance programs are now required to report certain information to HHS. This fact sheet describes how these federal reporting requirements affect comparable state disclosure laws. More info |
Issue Brief |
Joint Comments with Medtronic to CMS on Sunshine ImplementationThe Pew Charitable Trusts “Pew” and Medtronic, Inc. are pleased to jointly comment on the Department of Health and Human Services, Centers for Medicare & Medicaid Services proposed rule implementing Section 6002 of the Affordable Care Act. More info |
Issue Brief |
Joint Letter to HHS on Sunshine ImplementationDear Secretary Sebelius: We are writing to urge you to fully implement Section 1128G of the Social Security Act, the Physician Payments Sunshine Provision, which was added as Section 6002 of the Patient Protection and Affordable Care Act (PPACA). More info |
Issue Brief |
Legislative text of Physician Payment and other transparency provisions included in H.R. 3590Legislative text of Physician Payment and other transparency provisions included in H.R. 3590: Patient Protection and Affordable Care Act of 2009. Passed by the Senate (12/24/09) and the House (3/21/10). More info |
Issue Brief |
Letter from Pew to CMS Regarding Physician Payments Sunshine ActPrescription project director Danny Carlat identifies issues with the Physician Payments Sunshine Act requiring further clarification and guidance. Addressing those would ensure that manufacturers can appropriately implement the final rule, and enable consumers to benefit from transparency reports published by the Centers for Medicare & Medicaid Services. More info |
Issue Brief |
MedPAC Recommendations - Public Reporting of Physicians' Financial RelationshipsFinal recommendations approved by commission on November 6, 2008 - five recommendations to Congress regarding legislation about disclosure of relationships and gifts and payments made to physicians from pharmaceutical and medical device/supply manufacturers. More info |
Issue Brief |
Non-physician Prescribers and Pharmaceutical Industry InteractionsIndustry marketing to non-physician prescribers has increased markedly in recent years to roughly 20 million detail visits in 2006, a 20% increase over 2004. More info |
Issue Brief |
One Step Closer to Medical Transparency: Pew's Analysis of the Final Rule for the Physician Payments Sunshine ActOn Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights. More info |
Other Resource |
Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and PatientsIn 2011, the pharmaceutical industry spent nearly $29 billion on drug promotion — more than $25 billion on marketing directly to physicians and almost $4 billion on advertising directly to consumers (mainly through television commercials). This multi-pronged approach is designed to promote its products by influencing doctors’ prescribing practices. More info |
Other Resource |